Alvimopan Capsule
Product Images NDC 0254-3012
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Alvimopan (NDC 0254-3012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Alvimopan Capsules 2)
Figure 2 (Alvimopan Capsules 3)
This appears to be a graph showing the estimated probability of achieving Encipoint, with Alvimopan and Placebo as the two options. The x-axis shows the hours after the end of surgery, while the y-axis shows the percentage chance of achieving Encipoint. The data is presented in a colored, bar graph format.*
Alvimopan Carton (Alvimopan Capsules 4)
This is a product description of Alvimopan capsules. The capsules contain 12mg of Ahimogan and are only available by prescription. A package includes 30 unit-dose capsules (6 x 5 capsules). The usual dosage must be referred to from the package insert. This product is for hospital use only and should be kept at 25°C (77°F) or between 15°C to 30°C (59°F to 86°F). The manufacturer is Dby Parbramaces.*
Alvimopan Blister (Alvimopan Capsules 5)
This is a description of Alvimopan Capsule, with a 12 mg strength. The product is intended for hospital use only and is distributed by Par Pharmaceutical. The product is manufactured in India with a manufacturing license number of 25/82/2020. The capsule has markings indicating it should be pushed through from the front.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.